The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study
Abstract
Objective: Despite widespread use of colchicine, the evidence basis for oral colchicine therapy and dosing in acute gout remains limited. The aim of this trial was to compare low‐dose colchicine (abbreviated at 1 hour) and high‐dose colchicine (prolonged over 6 hours) with placebo in gout flare, using regimens producing comparable maximum plasma concentrations in healthy volunteers. Methods: This multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study compared self‐administered low‐dose colchicine (1.8 mg total over 1 hour) and high‐dose colchicine (4.8 mg total over 6 hours) with placebo. The primary end point was ≥50% pain reduction at 24 hours without rescue medication. Results: There were 184 patients in the intent‐to‐treat analysis. Responders included 28 of 74 patients (37.8%) in the low‐dose group, 17 of 52 patients (32.7%) in the high‐dose group, and 9 of 58 patients (15.5%) in the placebo group ( P = 0.005 and P = 0.034, respectively, versus placebo). Rescue medication was taken within the first 24 hours by 23 patients (31.1%) in the low‐dose group ( P = 0.027 versus placebo), 18 patients (34.6%) in the high‐dose group ( P = 0.103 versus placebo), and 29 patients (50.0%) in the placebo group. The low‐dose group had an adverse event (AE) profile similar to that of the placebo group, with an odds ratio (OR) of 1.5 (95% confidence interval [95% CI] 0.7–3.2). High‐dose colchicine was associated with significantly more diarrhea, vomiting, and other AEs compared with low‐dose colchicine or placebo. With high‐dose colchicine, 40 patients (76.9%) had diarrhea (OR 21.3 [95% CI 7.9–56.9]), 10 (19.2%) had severe diarrhea, and 9 (17.3%) had vomiting. With low‐dose colchicine, 23.0% of the patients had diarrhea (OR 1.9 [95% CI 0.8–4.8]), none had severe diarrhea, and none had vomiting. Conclusion: Low‐dose colchicine yielded both maximum plasma concentration and early gout flare efficacy comparable with that of high‐dose colchicine, with a safety profile indistinguishable from that of placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of the acute arthritis of primary gout
Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., Mccarty, D. J., & Yü, T. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200320 · Cited by 1,432
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Emmerson, B. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340707 · Cited by 516
Terkeltaub, R. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030733 · Cited by 456
Self-citationJanssens, H. J., Janssen, M., van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60799-0 · Cited by 317
Terkeltaub, R. A. (2009) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.006 · Cited by 299
Self-citationDOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT
AHERN, M. J., REID, C., GORDON, T. P., McCREDlE, M., BROOKS, P. M., & JONES, M. (1987) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1987.tb01232.x · Cited by 284
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Palo, W. A., Eustace, D., Vernillet, L., & Joseph‐Ridge, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20935 · Cited by 266
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis
Schumacher Jr, H. R., Boice, J. A., Daikh, D. I., Mukhopadhyay, S., Malmstrom, K., Ng, J., Tate, G. A., & Molina, J. (2002) · BMJ · doi:10.1136/bmj.324.7352.1488 · Cited by 238
Rubin, B. R., Burton, R., Navarra, S., Antigua, J., Londoño, J., Pryhuber, K. G., Lund, M., Chen, E., Najarian, D. K., Petruschke, R. A., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20007 · Cited by 188
Unmet Needs in the Management of Neuropathic Pain
Harden, N., & Cohen, M. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00065-4 · Cited by 185
van Echteld, I., Wechalekar, M. D., Schlesinger, N., Buchbinder, R., & Aletaha, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006190.pub2 · Cited by 162
Hung, I. F., Wu, A. K. L., Cheng, V. C., Tang, B. S. F., To, K. K., Yeung, C., Woo, P. C. Y., Lau, S. K. P., Cheung, B., & Yuen, K. (2005) · Clinical Infectious Diseases · doi:10.1086/431592 · Cited by 130
What Is a Meaningful Pain Reduction in Patients With Complex Regional Pain Syndrome Type 1?
Forouzanfar, T., Weber, W. E. J., Kemler, M. A., & van Kleef, M. (2003) · Clinical Journal of Pain · doi:10.1097/00002508-200309000-00001 · Cited by 88
Acute Colchicine Intoxication During Clarithromycin Administration
Rollot, F., Pajot, O., Chauvelot‐Moachon, L., et al. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e197 · Cited by 77
Quantifying meaningful changes in pain
Campbell, W., & Patterson, C. C. (1998) · Anaesthesia · doi:10.1046/j.1365-2044.1998.00294.x · Cited by 68
Cited by
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Self-citationDalbeth, N., Gosling, A. L., Gaffo, A., & Abhishek, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00569-9 · Cited by 1,338
Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Colchicine—Update on mechanisms of action and therapeutic uses
Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.013 · Cited by 950
Metadata
- Authors
- Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-03-30
- Volume
- 62
- Issue
- 4
- Pages
- 1060-1068
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2094780098
- Cited by
- 536
- References
- 17
- FWCI
- 28.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.